University Hospital Ghent

A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program (2023) de Fijter J, Dreyer G, Mallat M, Budde K, Pratschke J, Klempnauer J, Zeier M, et al. Journal article Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis. (2023) Campochiaro C, Hoffmann-Vold AM, Avouac J, Henes J, de Vries-Bouwstra J, Smith V, Siegert E, et al. Journal article Early versus Later Anticoagulation for Stroke with Atrial Fibrillation. (2023) Fischer U, Koga M, Strbian D, Branca M, Abend S, Trelle S, Paciaroni M, et al. Journal article In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation (2023) Jensen BEO, Knops E, Cords L, Lübke N, Salgado M, Busman-Sahay K, Estes JD, et al. Journal article, Original article Respiratory virome profiles reflect antiviral immune responses (2023) Rovira Rubió J, Megremis S, Pasioti M, Lakoumentas J, Constantinides B, Xepapadaki P, Bachert C, et al. Journal article Clinical implementation of RNA sequencing for Mendelian disease diagnostics (2022) Yépez VA, Gusic M, Kopajtich R, Mertes C, Smith NH, Alston CL, Ban R, et al. Journal article Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort (2022) Kuster S, Jordan S, Elhai M, Held U, Steigmiller K, Bruni C, Cacciapaglia F, et al. Journal article Vascular supply of the metacarpophalangeal joint (2022) Baksa G, Czeibert K, Sharp V, Handschuh S, Gyebnar J, Barany L, Benis S, et al. Journal article Persistent inflammation in systemic sclerosis is strongly associated with mortality: a EUSTAR database analysis (2022) Guler SA, Sarbu A, Stadler O, Allanore Y, Bernardino , Distler J, Gabrielli A, et al. Conference contribution How Well Does Ultrasound-assessed Synovitis in Reduced Joint Sets Predict the Response to Secukinumab in Patients with Active Psoriatic Arthritis and Inadequate Response to Conventional DMARDs? - Exploratory Results from a Phase 3b Study (2022) D'Agostino MA, Conaghan PG, Gaillez C, Naredo E, Mandl P, Carron P, Senolt L, et al. Conference contribution